Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
06/2006
06/21/2006EP1049662B1 Inhibitors of alpha4 mediated cell adhesion
06/21/2006EP1025106B1 Allosteric adenosine receptor modulators
06/21/2006EP0957080B1 Novel ethylamine derivatives
06/21/2006CN1791592A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions
06/21/2006CN1791591A Bioreductively-activated prodrugs
06/21/2006CN1791572A Novel compounds
06/21/2006CN1791570A Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
06/21/2006CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
06/21/2006CN1260224C Chloromethylation of thiophene
06/21/2006CN1260220C Tricyclic compounds
06/21/2006CN1260218C PDF enzyme inhibitor-hydroxamic acid serial compounds, synthetic method and use thereof
06/21/2006CN1260214C Heterofluorene highly branched derivative with strong two photon absorption characteristics
06/20/2006US7064122 Pancreatic lipase inhibitor compounds, their synthesis and use
06/20/2006US7063928 An apparatus having an organophotoreceptor in the form of a flexible belt threaded around support rollers and having a charge transfer compound comprising a fluorenone hydrazone including other functional groups and phenyl and heteraryl rings;used with liquid toner; durability
06/20/2006CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
06/20/2006CA2121523C Sulfonamide derivatives
06/15/2006WO2006062249A1 Substituted heterocyclic compound and thrombopoietin receptor activator
06/15/2006WO2006062247A1 Substituted heterocyclic compound and thrombopoietin receptor activator
06/15/2006WO2006062240A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
06/15/2006WO2006062093A1 Novel anthranilic acid derivative or salt thereof
06/15/2006WO2006061392A2 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
06/15/2006WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides
06/15/2006WO2005122698A3 Novel stable polymorphic forms of tiagabine hydrochloride
06/15/2006WO2005085188A3 Compounds and methods for anti-tumor therapy
06/15/2006US20060128974 Cyclometallated complexes of a group 9 or 10 element prepared from an iminated thiophenecarboxaldehyde and a monoanionic beta-diketone ligand or a monoanionic bidentate chelate ligand having a carboxyl group or a phenolic hydroxyl group; used in devices that operate at low voltage with high efficiency
06/15/2006US20060128791 3-Methylamino-1-(2-thienyl)-1-propanone, production and use thereof
06/15/2006US20060128670 Pesticidally active ketone and oxime derivatives
06/15/2006US20060128662 Novel compounds for treatment of obesity
06/15/2006CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides
06/15/2006CA2588979A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
06/15/2006CA2588760A1 Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives
06/15/2006CA2588633A1 Novel anthranilic acid derivative or salt thereof
06/14/2006EP1669345A1 Ester derivative and medicinal use thereof
06/14/2006EP1667964A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
06/14/2006EP1667959A1 Biphenyloxy-acids
06/14/2006EP1163553B1 Oxime derivatives and the use thereof as photoinitiators
06/14/2006EP0966283B1 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
06/14/2006CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient
06/14/2006CN1787988A Arylamine compound and organic electroluminescence device containing the same
06/14/2006CN1786010A Diarene compound, its preparation method and application
06/14/2006CN1785959A Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/13/2006US7060846 Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
06/13/2006US7060700 Amide derivatives useful as inhibitors of the production of cytokines
06/13/2006CA2260777C Pentafluorobenzenesulfonamides and analogs
06/13/2006CA2237194C Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants
06/13/2006CA2180008C Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
06/08/2006WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006WO2006058699A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides
06/08/2006WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors
06/08/2006US20060122418 Method for producing an optically active beta-amino acid
06/08/2006US20060122405 Preparation of 3-methylamino-1-phenyl-1-propanone or 3-methylamino-1-(2-thienyl)-1-propanone; chemical intermediates to central nervous system drugs such as fluoxetine, tomoxetine
06/08/2006US20060122402 Manufacturing process for no-donating compounds such as no-donating diclofenac
06/08/2006US20060122386 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators
06/08/2006US20060122364 Process for producing dendrimer, building block compound, and process for producing thiophene compound
06/08/2006US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders
06/08/2006US20060122257 Phenyl substituted carboxylic acids
06/08/2006US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents
06/08/2006US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
06/08/2006US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
06/08/2006US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate
06/08/2006US20060122183 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer
06/08/2006US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof
06/08/2006US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
06/08/2006US20060122061 Arylphenyl-substituted cyclic ketoenols
06/08/2006CA2589010A1 Biaryloxymethylarene carboxylic acids
06/08/2006CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006CA2583335A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides
06/08/2006CA2558647A1 Insecticidal n-substituted sulfoximines
06/07/2006EP1664015A1 Substituted naphthyl benzothiophene acids
06/07/2006EP1664014A2 Process for the asymmetric hydrogenation of beta-amino ketones
06/07/2006EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
06/07/2006EP1663960A2 Amidines and derivatives thereof and pharmaceutical compositions containing them
06/07/2006EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors
06/07/2006EP1663953A1 Inhibitors of histone deacetylase
06/07/2006EP1663936A1 Biaryloxymethylarene-carboxylic acids
06/07/2006EP1663934A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds
06/07/2006EP1663919A2 Compounds based on fluoranthene and use thereof
06/07/2006EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same
06/07/2006EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
06/07/2006CN1784399A 3-carbonylaminothiophenes and their use as fungicides
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
06/06/2006US7057054 Hexafluorocyclopentene di-substituted with an alkoxy- and aryl-substituted furan and/or thiophene; e.g., 1,2-bis(2-methoxy-5-phenyl-3-thienyl)hexafluorocyclopentene; nonfading
06/06/2006US7057038 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
06/06/2006US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
06/06/2006US7056922 Acylamino cyclopropane derivatives
06/06/2006US7056902 4-dedimethylamino tetracycline compounds
06/06/2006CA2232913C Process for the preparation of azide derivatives
06/06/2006CA2213810C Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
06/06/2006CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives
06/01/2006WO2006058063A1 2,3,4-substituted-cyclopentanones as therapeutic agents
06/01/2006WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors
06/01/2006WO2006057326A1 Pyrene compound and light emitting transistor device utilizing the same
06/01/2006WO2006056752A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases
06/01/2006WO2006056462A1 Azine compounds for combating animal pests
06/01/2006US20060117348 System and method for displaying editorial content through television navigation controls and electronic program guides
06/01/2006US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis
06/01/2006US20060116419 Nf-kb inhibitors
06/01/2006US20060116408 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents; methyl 4-(5-chloro-3-methylbenzo[b]thiophene-2-sulfonylamino)-3-methanesulfonylbenzoate
06/01/2006US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses